Aztron Medtech Surpasses 100 U.S. TendMIN® Procedures, Reflecting Sustained Adoption in Minimally Invasive Achilles Tendon Repair
Aztron Medtech, a privately held orthopedic device company, today announced that more than 100 clinical procedures have now been performed in the United States using its TendMIN® Minimally Invasive Achilles Tendon Repair System, marking a significant milestone in the system’s continued clinical adoption.
Aztron Medtech and Lovell Government Services Secure FSS, ECAT and GSA Listings, Expanding U.S. Government Access to TendMIN™ Achilles Tendon Repair System
Aztron Medtech, a privately held orthopedic device company, today announced that its flagship product, the TendMIN™ Minimally Invasive Achilles Repair System, is now listed on the Federal Supply Schedule (FSS), the Defense Logistics Agency’s Electronic Catalog (ECAT) and the GSA Advantage platform through its partnership with Lovell Government Services (LGS), a Service-Disabled Veteran-Owned Small Business (SDVOSB) and authorized federal contracting partner. These listings allow federal health systems, including the Department of Defense (DoD) and Veterans Affairs (VA) medical facilities, to purchase TendMIN™ directly through established government procurement channels.
Aztron Medtech Completes 50th U.S. TendMIN™ Procedure in Minimally Invasive Achilles Repair, Signaling Strong Early Adoption
Aztron Medtech, a privately held orthopedic device company, today announced the completion of the 50th clinical case in the United States utilizing its TendMIN™ percutaneous Achilles tendon repair system.
